201 related articles for article (PubMed ID: 19702885)
1. Bypassing agent prophylaxis for preventing arthropathy in patients with inhibitors.
Ewenstein BM; Wong WY; Schoppmann A
Haemophilia; 2010 Jan; 16(1):179-80. PubMed ID: 19702885
[No Abstract] [Full Text] [Related]
2. When should prophylaxis therapy in inhibitor patients be considered?
Young G; Auerswald G; Jimenez-Yuste V; Konkle BA; Lambert T; Morfini M; Santagostino E; Blanchette V
Haemophilia; 2011 Sep; 17(5):e849-57. PubMed ID: 21418444
[TBL] [Abstract][Full Text] [Related]
3. Prevention of haemophilic arthropathy in haemophilic children with inhibitors.
Rodriguez-Merchan EC
Haemophilia; 2008 Nov; 14 Suppl 6():1-3. PubMed ID: 19134025
[TBL] [Abstract][Full Text] [Related]
4. Experiences in the prevention of arthropathy in haemophila patients with inhibitors.
Jimenez-Yuste V; Rodriguez-Merchan EC; Alvarez MT; Quintana M; Martin-Salces M; Hernandez-Navarro F
Haemophilia; 2008 Nov; 14 Suppl 6():28-35. PubMed ID: 19134031
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis in haemophilia patients with inhibitors.
Leissinger CA
Haemophilia; 2006 Dec; 12 Suppl 6():67-72; discussion 72-3. PubMed ID: 17123397
[TBL] [Abstract][Full Text] [Related]
6. Some recent developments regarding arthropathy and inhibitors in haemophilia.
Rodriguez-Merchan EC
Haemophilia; 2008 Mar; 14(2):242-7. PubMed ID: 18201189
[TBL] [Abstract][Full Text] [Related]
7. Re: Discordant pair analysis of rFVIIa and pd-aPCC response.
Cooper DL; Seremetis S; Carr ME
Haemophilia; 2011 Mar; 17(2):323-5. PubMed ID: 21332885
[No Abstract] [Full Text] [Related]
8. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations.
Jiménez-Yuste V; Alvarez MT; Martín-Salces M; Quintana M; Rodriguez-Merchan C; Lopez-Cabarcos C; Velasco F; Hernández-Navarro F
Haemophilia; 2009 Jan; 15(1):203-9. PubMed ID: 19149850
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis in congenital coagulation disorders: past, present and future.
Mannucci PM
Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s1-3. PubMed ID: 19105502
[No Abstract] [Full Text] [Related]
10. Prevention of arthropathy in haemophilia - intensive on-demand treatment, UK perspective.
Lee CA
Haemophilia; 2008 Nov; 14 Suppl 6():11-5. PubMed ID: 19134027
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis in haemophilia with inhibitors: update from international experience.
Carcao M; Lambert T
Haemophilia; 2010 Mar; 16 Suppl 2():16-23. PubMed ID: 20132334
[TBL] [Abstract][Full Text] [Related]
12. How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors.
Leissinger CA; Singleton T; Kruse-Jarres R
Blood; 2015 Jul; 126(2):153-9. PubMed ID: 25827834
[TBL] [Abstract][Full Text] [Related]
13. Control of variceal bleeding in a patient with severe haemophilia A and factor VIII inhibitors using a transjugular intrahepatic portosystemic shunt.
Hurst E; Talks K; Hanley J
Haemophilia; 2010 Jul; 16(4):708-9. PubMed ID: 20398076
[No Abstract] [Full Text] [Related]
14. Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs.
Santagostino E; Morfini M; Auerswald GK; Benson GM; Salek SZ; Lambert T; Salaj P; Jimenez-Yuste V; Ljung RC
Haemophilia; 2009 Sep; 15(5):983-9. PubMed ID: 19712172
[TBL] [Abstract][Full Text] [Related]
15. Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10).
Hedner U
Haemophilia; 2010 Mar; 16(2):372-3. PubMed ID: 20028420
[No Abstract] [Full Text] [Related]
16. Prevention of bleeding in hemophilia patients with high-titer inhibitors.
Leissinger CA; Konkle BA; Antunes SV
Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074
[TBL] [Abstract][Full Text] [Related]
17. Successful total hip replacement with sequential administration of bypassing agents in an adolescent boy with hemophilia A and high inhibitor titers.
Kaya Z; Orhan Ö; Turanlı S; Yenicesu İ; Koçak Ü; Gürsel T
Blood Coagul Fibrinolysis; 2017 Jul; 28(5):419-422. PubMed ID: 28079537
[TBL] [Abstract][Full Text] [Related]
18. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors.
Hough RE; Hampton KK; Preston FE; Channer KS; West J; Makris M
Br J Haematol; 2000 Dec; 111(3):974-9. PubMed ID: 11122162
[TBL] [Abstract][Full Text] [Related]
19. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
Valentino LA
Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380
[TBL] [Abstract][Full Text] [Related]
20. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
